PCVAX | SSGSX | PCVAX / SSGSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 26 years | - |
Gain YTD | 11.646 | 2.915 | 400% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 316M | 7.03B | 4% |
Annual Yield % from dividends | 2.15 | 0.35 | 605% |
Returns for 1 year | 3.73 | 4.35 | 86% |
Returns for 3 years | -7.11 | -0.70 | 1,021% |
Returns for 5 years | -2.46 | 9.53 | -26% |
Returns for 10 years | -43.73 | 18.43 | -237% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PYVAX | 19.30 | N/A | N/A |
Payden Equity Income Adviser | |||
DUSLX | 39.27 | -0.15 | -0.38% |
DFA US Large Cap Growth Instl | |||
RIRGX | 72.76 | -0.37 | -0.51% |
American Funds Capital Income Bldr R6 | |||
VALLX | 39.77 | -0.29 | -0.72% |
Value Line Larger Companies Focused Inv | |||
APGRX | 20.57 | -0.18 | -0.87% |
Yorktown Growth Institutional |